Find out how our vast clinical trial supply experience can benefit you We are attending the Clinical Outsourcing Group UK conference on the 21st and 22nd of February in London. Visit our team of experts at booth 23 or pre-book a meeting with our Managing Director, Vanessa Dekou, to discuss your trial and protocol requirements. Our team will show you how you can benefit from our extensive experience in clinical trial supplies and our trusted network of warehouse suppliers across 6 continents, leveraging our scientific expertise and industry knowledge. Vanessa will be speaking on day 1, at 11:45 am, on Comparator Sourcing: An Enabling Step in the Process of Successful Clinical Trials. Clinical trials cannot take place without patients, IMP and standard-of-care comparator medication. Comparators enable and facilitate the conduct of a successful clinical trial so that no patient is turned away from the site due to a lack of medication. In her presentation, Vanessa will discuss the challenges in sourcing comparators on a global scale and remedies to mitigate risk even for the most complex phase 3 adaptive trials. We look forward to meeting UK executives and trial sponsors for two incredible days of networking and innovation! Meeting spaces are limited, so please book in advance.

Csi is delighted to announce that we will be attending and exhibiting at oct barcelona on 4th and 5th may 2023. CSI is delighted to announce that we will be attending and exhibiting at OCT Barcelona on 3rd and 4th May 2023. We look forward to networking with clients, trial sponsors and peers. In attendance will be our Managing Director, Vanessa Dekou, accompanied by CSI’s leaders in strategy and supply chain. You can meet with the CSI team to address outsourcing challenges, discuss your upcoming pipeline requirements and sourcing strategies for clinical trials. If you haven’t registered yet, you can register via the link here. You can also contact us directly to pre-book any meetings across the event. We look forward to meeting you.

24-25th november, Mövenpick hotel zürich-regensdorf, Zurich, Switzerland Email us at info@csint.com to book a meeting with our experts! Find out more about the upcoming event here.

For young people, learning to manage the condition is so important. There is a wealth of information out there that can help youths understand the effects of the condition, how to treat it and how to manage it through their lifetime. Caring for the mental health of young people is also crucial. Dealing with a chronic condition can be a frightening and confusing time. Moving into adult care as they grow up with diabetes will also take time to understand the transition and how their treatment may change. What are the types of diabetes? Diabetes affects the levels of insulin in a person’s blood. There are two forms of diabetes; type 1 and type 2. Type 1 diabetes results from the body’s failure to produce insulin which leads to a high level of glucose in the bloodstream. It is treated by injecting insulin into the body daily to keep blood glucose levels under control. Type 2 diabetes means your body cannot make enough insulin or make the insulin it produces work properly. This type can be treated with medicated insulin, and it can also be managed through a healthy diet and exercise. How is diabetes treated? The medicine diabetes patients take depends on the type of diabetes they have and how well the medicine controls their blood glucose levels. Different diabetes treatments work in different ways to lower blood sugar and often a combination of medicines is required to treat the condition effectively. Type 1 diabetes must use insulin as the body cannot produce it. It is the most common type of diabetes in children. Type 2 diabetes does not always require insulin, it can be managed with a healthy lifestyle, oral medication or some may need insulin depending on the patient. Medication can change over time depending on how your body reacts at different stages of the chronic condition. Young people with diabetes will experience a change in medication or lifestyle as they transition into adult care. A management plan can help young people understand their diabetes care. The plan should outline how to manage blood glucose levels, encourage healthy eating habits, encourage physical movement, prepare for emergencies and seek mental health support. A diabetes management plan can support young people to take actionable steps towards their condition care. Insulin treatment There are different types of insulin available to treat diabetes. Each type works at different speeds and the effects last a different length of time. They can be administered in many ways depending on the patient’s preference. The type of insulin prescribed by doctors depends on the type of diabetes, how the body reacts to the treatment, other health conditions and the patient’s financial position. Young people will need support from parents or carers when administering insulin if they find it uncomfortable or are too young to handle the needles themselves. As they get older, they will eventually be able to do this without any help. Types of insulin: Rapid-acting - works 15 minutes after injection, peaks at 1 hour, lasts 2 to 4 hours Short-acting - works 30 minutes after injection, peaks at 2 to 3 hours, lasts 3 to 6 hours Intermediate-acting - works 2 to 4 hours after injection, peaks at 4 to 12 hours, lasts 12 to 18 hours Long-acting - works several hours after injection, does not peak, lasts for 24 hours. Types of insulin administration: Needle and syringe - draw the dose of insulin from the vial into the syringe and inject it into the belly, thigh, buttocks or upper arm once or two to four times a day. Pen - some come filled with insulin and are disposable and others require patients to insert an insulin cartridge and replace after use. Pens cost more than needles but are easier to use. Pump - provides a small, steady dose of insulin throughout the day. Insulin pumps from the pack worn outside the body through the tube and into the needle inserted under the skin. The needle lasts for several days and pumps insulin into the body 24 hours a day. Importance of diabetes clinical trial participation Diabetes clinical trials are essential to understand more about the disease and how it affects those diagnosed and pre-diagnosed. Before diabetes treatments can reach patients, they must be carefully tested in clinical trials. People with diabetes are crucial to the success of clinical trials. Clinical trial participation ensures scientists and researchers can understand the timelines of recognising symptoms and diagnosing diabetes. Diabetes patients can get involved in clinical trials to test medication and learn which treatments are or are not the most effective for the type of diabetes they have. Researchers can learn which medicine has the fewest side effects and which are the most helpful for long-term diabetes treatment. For example, The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study is looking into the lives of over 5,000 people in the United States with type 2 diabetes to find out which combination of two medications is best for blood sugar management. Clinical trials can look into the genetics behind diabetes and the risks associated with relatives of people with type 1 diabetes. This is referred to as prediabetes. For example, TrialNet is conducting research that includes risk screening for relatives of those diagnosed with type 1 diabetes and how to slow down the disease. Clinical trials also study other aspects of care such as improving the quality of life for people with chronic illnesses. Diabetes is a chronic condition that affects the lives of hundreds of thousands of young people in the United States. Raising awareness of the disease and its treatment is imperative for young children to receive the support and care they need. Taking part in clinical trials improves the progress made in diabetes research. Coming together, communities can bring attention to diabetes to learn how to best manage, treat and slow down this disease. At CSI we have worked on many diabetes studies and have assisted successfully delivering thousands of pens all over the world. We have well-established relationships with all leading manufacturers and as such we can provide cost-efficient and timely solutions and design a robust supply chain to advance your trial.

We have been featured in the clinical trial supply handbook (cts) 2021! We’re thrilled to be featured in the Clinical Trial Supply Handbook (CTS) 2021! The article showcases our expertise in the role of comparators in clinical trial supply and designs. Check out our feature in the CTS Handbook 2021. Read our feature here. Here’s what you can expect to learn: Why active comparators are used in clinical trials Important questions to ask when sourcing comparators Real-life comparator case studies and how CSI addressed all challenges. The CTS handbook is the go-to guide for professionals in the global clinical supply space. It’s a knowledge base for the clinical supply community featuring content from leading industry experts including CSI. If you liked our article, we’d love to discuss your clinical trial requirements and how we can support you. If you want to find out how CSI can support your clinical trial, contact us for a chat CSI is a world leader in the sourcing and management of quality certified commercially available medicines (comparators) for clinical trials. Our long-standing experience in sourcing and clinical trials enables us to provide custom made solutions to address the most complex requirements.

Csi is attending clinical trial supply europe 2021 CSI is attending Clinical Trial Supply Europe Virtual Conference. We want to use this opportunity to catch up with you virtually. Location: Virtual Event Date: 24th-25th March 2021 Time: 8:45 AM CET Please get in touch with us to arrange a meeting with our team at CTS Europe. Arrange a meeting

November 16-19, 2021 London, uk This year marks the 12th anniversary of the largest healthcare-dedicated conference in Europe. In 2020, we hosted over 550 participating companies, 3,000 attendees, and 6,500 business-to-business and investor meetings. Our conference will again feature leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia. Jefferies remains vigilantly focused on the health, safety and well-being of our clients & employees. Conditions permitting, and with protocols in place, we plan to host the conference in London on Tuesday, November 16 & Wednesday, November 17 and virtually on Thursday, November 18 & Friday, November 19. Registration for the conference is now open. Please contact your Jefferies representative to regiser. For question, please email londonhealthcareconf@jefferies.com

8-9th December, London, UK Email us at info@csint.com to book a meeting with our experts! Find out more about the upcoming event here.

22nd-23rd march 2022 , novotel madrid center hotel We are attending Clinical Trial Supply Europe 2022 at the Novotel Madrid Center Hotel on 22nd-23rd March 2022. If you are attending the event and would like to arrange a meeting with one of our scientific experts, you can do this by following this link. Alternatively, you can find out more about the upcoming event by clicking here.

Csi is attending outsourcing in clinical trials europe 2022 4-5th May, Hyatt Regency Barcelona Tower, Barcelona, Spain. Email us at info@csint.com to book a meeting with our experts! Find out more about the upcoming event here.

01-03 november2022, messe frankfurt, germany. Our Managing Director, Vanessa Dekou PhD, MBA is attending CPHI Frankfurt on 01-03 November. If you are going to the event and would like to book a meeting with her, please click here. You can also find out more about the event here.

The CSIteam is exhibiting at the cog new england event in boston on 18th – 19th april The CSI Team is exhibiting at the COG New England event in Boston on 18th – 19th April for two days of invaluable networking. We look forward to meeting you to discuss upcoming protocols and study pipelines. Our Managing Director, Vanessa Dekou, will be hosting an insightful presentation on Tuesday 18th April at 9:00am. You can meet with our team at Booth 19 during the event or book a meeting in advance here.